Allarity (ALLR) Therapeutics announced the appointment of Jeff Ervin as the Company’s new CFO. He succeeds Alexander Epshinsky, who will remain engaged with the Company during a transition period. He most recently served as Co-CFO at DayDayCook and was previously CEO of IMAC Holdings.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLR:
- Allarity Therapeutics Secures Australian Patent for DRP® Platform
- Allarity Therapeutics Advances Phase 2 Stenoparib Trial
- Allarity gets Australian patent acceptance notice for DRP companion diagnostic
- Allarity announces second patient dosed in Phase 2 trial of stenoparib
- Allarity Therapeutics Holds Annual Stockholders Meeting